Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,606 public trials 547 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe

NCT04937777

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Allgemeines Krankenhaus Der Stadt Wien (General Hopsital), Universitätsklinik Für Innere Medizin I Klinische Abteilung Für Onkologie (Clinic of Internal Medicine I), Medizinische Universität Wien Vienna, Austria
  • University Hospital Ostrava, Clinic of Hematooncology Ostrava, Czechia
  • Centre Hospitalier Universitaire de Limoges, Department of Clinical Hematology and Cell Therapy Limoges, France
  • Service de Néphrologie, Hémodialyse Et Transplantation Rénale, Hôpital Jean Bernard, Chu Poitiers Poitiers, France
View all 13 locations
View Trial Details
Completed

A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma

NCT01677858

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Comprehensive Blood and Cancer Center (CCBC) Bakersfield, California, United States
  • California Cancer Associates for Research and Excellence Encinitas, California, United States
  • Robert A. Moss, M.D., FACP, Inc. Fountain Valley, California, United States
View all 35 locations
View Trial Details
Completed

Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma

NCT02412878

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Research Site Scottsdale, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Research Site Bethesda, Maryland, United States
  • Center for Cancer and Blood Disorders Bethesda, Maryland, United States
View all 140 locations
View Trial Details
Completed

Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma

NCT01080391

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • Providence St. Joseph Medical Center Burbank, California, United States
  • St. Jude Hospital Yorba Linda dba; St. Joseph Heritage Healthcare Santa Rosa, California, United States
  • Stanford University Stanford, California, United States
View all 127 locations
View Trial Details
Completed

Multiple Myeloma Minimal Residual Disease

NCT02627261

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Hôpital Huriez Lille, France
  • Centre Hospitalier Universitaire Hôtel-Dieu de Nantes Nantes, France
  • Centre Hospitalier Lyon Sud Pierre Bénité, France
View Trial Details

Related conditions